We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · May 17, 2021

Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis



Additional Info

Disclosure statements are available on the authors' profiles:

Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial
Circulation 2021 Apr 29;[EPub Ahead of Print], TA Pawade, MK Doris, R Bing, AC White, L Forsyth, E Evans, C Graham, MC Williams, EJR van Beek, A Fletcher, PD Adamson, JPM Andrews, TRG Cartlidge, WSA Jenkins, M Syed, T Fujisawa, C Lucatelli, W Fraser, SH Ralston, N Boon, B Prendergast, DE Newby, MR Dweck

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading